ArticleTrials2023

Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trial.

Edward L Snyder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.